Last update June 1, 2020
Very Low Risk
Although antibodies and RNA from the disease have been detected in colostrum (García 2015), no case of infection has been documented in numerous studies that have been carried out, so there is consensus among authors and scientific associations that there is no need to suspend breastfeeding in mothers with hepatitis C (Compagnone 2019, Dibba 2018, Post 2017, SMFM 2017, Tovo 2016, AAP 2015, Workowski-CDC 2015 and 2010, Lawrence 2013, Cottrell 2013, Durmaz 2012, Le Campion 2012, Madurga 2012, Arshad 2011, Bhola 2007, Sookoian 2006, Pembrey 2005, Kumar 1998).
There are no differences in the frequency of transmission in groups of breastfed children compared to those fed with artificial milk (Townsend 2012, Lanari 2012, Fiore 2009, Hay 2008, Bhola 2006, Lawrence 2004).
Breast milk inactivates the Hepatitis C virus (Tovo 2016, Pfaender 2013, Jhaveri 2013).
Vertical transmission (mother-to-child) rate of hepatitis C is 1% to 5%, with a higher risk if it coexists with HIV, illegal intravenous drug use and high viral load (more than 105 copies/mL).
Vertical transmission is independent of the delivery route (vaginal or cesarean section) and breastfeeding (Christensen 2014, Maher 2013, Cottrell 2013).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.